Skip to content

Gap CO2 in Septic Patient to Predict Cardiomyopathy Septic

Gap CO2 in Septic Patient to Predict Cardiomyopathy Septic

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06326762
Enrollment
98
Registered
2024-03-22
Start date
2023-01-01
Completion date
2023-10-30
Last updated
2024-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Defect, Cardiac Output, Low, Gap co2

Keywords

cardiac, CO2, septic

Brief summary

the investigators included 98 patients admitted for sepsis and septic shock (68.4% men, 31.6% women) with an average age of 60.42 years ± 15.13, ranging from 21 to 96 years. The average length of hospital stay was 7.53 days. The most noted medical histories were diabetes (38.8%), hypertension (28.6%), and renal insufficiency (17.1%). Regarding laboratory findings: the mean white blood cell count was 15,985.16 cells/mm³, the mean C-reactive protein (CRP) level was 227.69 mg/L, and the mean procalcitonin level was 50.43 µg/L. In terms of blood gas analysis: the mean lactate level was 3.67 mmol/L, and the mean PCO2 gap (DELTAPCO2) was 4.85. All our patients were continuously monitored by pulse wave analysis: the mean cardiac output was 5.69 L/min, and the mean cardiac index was 4.14 L/s/m² All our patients underwent an echocardiogram, which is a routine examination in our department and is performed at the patient's bedside. The average left ventricular ejection fraction (LVEF) was 51.73%, and the average subaortic peak velocity (ITV) was 14.66 cm. Subsequently. the investigators examined the clinical and paraclinical profile of patients with septic cardiomyopathy. the investigators identified 19 patients with this condition, while 79 patients did not exhibit cardiac involvement. The percentage was significantly higher in the population with cardiac involvement, accounting for 28.3%. Among the patients with cardiac involvement, 76.5% had a PCO2 gap (DELTAPCO2) ≥ 6 mmHg, a significantly reduced cardiac output with an average of 3.3 L/min, and a predominantly low cardiac index, with 64.3% having an index \< 2.2 L/min/m². The mortality rate was significantly increased at 73.7%.

Interventions

OTHERcomparaison

description indicate

Sponsors

Mohammed VI University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients admitted to the intensive care unit * sepsis or septic shock * at least one echocardiogram and were monitored by pulse wave contour analysis * stay of 72 hours in the intensive care unit

Exclusion criteria

* Patients without sepsis or septic shock. * Patients with COVID-19. * Patients who died within 48 hours of hospitalization. * Cases with incomplete medical records or patients not monitored. * Patient with pre-existing cardiac conditions. * post-operative patients from cardiac and thoracic surgeries.

Design outcomes

Primary

MeasureTime frameDescription
gapCO210 mounthssignificative in cardiomyopathy septic

Countries

Morocco

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026